Security Snapshot

MACROGENICS INC - Common Stock, par value $0.01 per share (MGNX) Institutional Ownership

CUSIP: 556099109

13F Institutional Holders and Ownership History from Q1 2014 to Q2 2026

Latest Period

Q2 2026

Institutions Reporting

122

Shares (Excl. Options)

48,694,210

Price

$4.62

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
+5,528,297
Value change
+$28,459,220
Number of holders
122
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
63,537,462
SEC-reported price per share
$3.67
Insider filing price
$3.67
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • MGNX - MACROGENICS INC - Common Stock, par value $0.01 per share is tracked under CUSIP 556099109.
  • 122 institutions reported positions in Q2 2026.
  • 5 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 108 to 122 between Q1 2026 and Q2 2026.
  • SEC-reported value moved from $124,750,835 to $224,942,277.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 122 institutions filings for Q2 2026.

Open SEC evidence

Security key

556099109

Latest holder period

Q2 2026

13F holders

122

13D/G owners

5

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
5
Security
MGNX
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ARMISTICE CAPITAL, LLC 7.9% -21% $23,131,194 -$6,085,686 5,006,752 -21% Armistice Capital, LLC 30 Jun 2026
BlackRock, Inc. 7.1% +140% $20,808,078 +$12,428,807 4,503,913 +148% BlackRock, Inc. 30 Jun 2026
BANK OF AMERICA CORP /DE/ 4% -22% $11,810,914 -$3,243,697 2,556,475 -22% BANK OF AMERICA CORP /DE/ 30 Jun 2026
MILLENNIUM MANAGEMENT LLC 3.7% -34% $10,969,722 -$4,902,993 2,374,296 -31% Millennium Management LLC 30 Jun 2026
WASATCH ADVISORS LP 3.1% -42% $3,276,482 -$2,584,186 1,950,287 -44% Wasatch Advisors LP 30 Sep 2025

As of 30 Jun 2026, 122 institutional investors reported holding 48,694,210 shares of MACROGENICS INC - Common Stock, par value $0.01 per share (MGNX). This represents 77% of the company’s total 63,537,462 outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
68%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
ARMISTICE CAPITAL, LLC 7.9% 5,006,752 -17% 0.64% $23,131,194
BlackRock, Inc. 7.4% 4,679,229 +302% 0% $21,618,040
VANGUARD CAPITAL MANAGEMENT LLC 4.2% 2,656,010 +0.08% 0% $12,270,766
RENAISSANCE TECHNOLOGIES LLC 4.1% 2,632,750 -11% 0.02% $12,163,305
ACADIAN ASSET MANAGEMENT LLC 4% 2,542,643 -0.05% 0.01% $11,740,000
BANK OF AMERICA CORP /DE/ 3.9% 2,488,252 +3.6% 0% $11,495,724
TWO SIGMA INVESTMENTS, LP 3.9% 2,465,699 -2.5% 0.01% $11,391,529
MILLENNIUM MANAGEMENT LLC 3.7% 2,374,296 -15% 0.01% $10,969,248
WASATCH ADVISORS LP 3.2% 2,018,881 +29% 0.06% $9,327,230
RA CAPITAL MANAGEMENT, L.P. 2.9% 1,864,176 0% 0.07% $8,612,493
VANGUARD PORTFOLIO MANAGEMENT LLC 2.9% 1,820,231 +51% 0% $8,409,467
MACKENZIE FINANCIAL CORP 2.6% 1,642,626 +175% 0.01% $7,588,932
MARSHALL WACE, LLP 2.5% 1,616,220 -20% 0.01% $7,466,936
GEODE CAPITAL MANAGEMENT, LLC 2.5% 1,576,549 +126% 0% $7,285,810
Affinity Asset Advisors, LLC 1.9% 1,216,606 +143% 0.27% $5,620,720
D. E. Shaw & Co., Inc. 1.7% 1,062,991 +0.43% 0% $4,911,018
JACOBS LEVY EQUITY MANAGEMENT, INC 1.6% 1,002,274 +127% 0.02% $4,630,506
Connor, Clark & Lunn Investment Management Ltd. 1.6% 1,000,412 +15% 0.01% $4,621,903
STATE STREET CORP 1.4% 863,663 +194% 0% $3,990,123
GOLDMAN SACHS GROUP INC 0.88% 558,001 +104% 0% $2,577,964
NORTHERN TRUST CORP 0.81% 516,129 +239% 0% $2,384,516
VANGUARD FIDUCIARY TRUST CO 0.66% 420,106 +24% 0% $1,940,890
NOMURA ASSET MANAGEMENT INTERNATIONAL INC. 0.66% 420,000 0% 0% $1,940,000
Walleye Capital LLC 0.64% 408,150 +22% 0.01% $1,885,653
DIMENSIONAL FUND ADVISORS LP 0.6% 379,335 +51% 0% $1,753,576

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
50
Latest
Q2 2026
Rows shown
1-25 of 50
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q2 48,694,210 $224,942,277 +$28,459,220 $4.62 122
2026 Q1 43,169,221 $124,750,835 +$13,216,317 $2.89 108
2025 Q4 39,873,697 $64,163,885 -$11,268,458 $1.61 87
2025 Q3 46,069,790 $77,396,729 -$2,543,825 $1.68 101
2025 Q2 48,254,634 $58,417,269 -$6,816,378 $1.21 109
2025 Q1 53,787,262 $68,275,226 -$6,563,237 $1.27 124
2024 Q4 56,086,649 $182,277,562 +$1,567,680 $3.25 125
2024 Q3 54,902,225 $180,609,672 -$21,573,575 $3.29 119
2024 Q2 60,780,167 $258,313,062 -$142,568,369 $4.25 141
2024 Q1 64,754,082 $953,179,892 +$47,766,062 $14.72 160
2023 Q4 61,853,452 $595,031,063 +$42,076,156 $9.62 135
2023 Q3 58,037,496 $270,452,676 -$10,612,704 $4.66 125
2023 Q2 60,016,268 $321,083,284 +$4,896,794 $5.35 128
2023 Q1 58,447,529 $419,062,824 +$13,088,841 $7.17 134
2022 Q4 56,759,894 $380,843,944 +$1,005,535 $6.71 132
2022 Q3 57,575,517 $199,204,006 -$24,411,977 $3.46 125
2022 Q2 62,614,291 $184,903,988 -$36,679,744 $2.95 122
2022 Q1 60,299,794 $531,229,517 +$2,906,259 $8.81 137
2021 Q4 57,195,769 $918,067,066 -$24,934,268 $16.05 150
2021 Q3 57,874,256 $1,211,800,601 -$1,579,067 $20.94 148
2021 Q2 57,205,089 $1,536,547,929 +$8,981,504 $26.86 145
2021 Q1 56,061,432 $1,785,526,852 +$84,404,214 $31.85 172
2020 Q4 53,782,589 $1,229,394,378 -$4,957,016 $22.86 142
2020 Q3 53,058,543 $1,336,560,085 +$57,695,259 $25.19 135
2020 Q2 50,654,768 $1,414,302,624 +$299,006,012 $27.92 131
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .